Curative Ventures V LLC portfolio
Latest available portfolio: Q2 2026 · Holdings as of · Filed · $14,603,341 in Form 13F holdings
See latest portfolio changesQuarterly portfolio filings
Choose a quarter to see holdings and changes. Newer portfolio dates appear first.
Estimated additions and reductions value share changes at filing-derived prices; they are not actual trade proceeds or costs.
| Quarter | Holdings | SEC-reported value | Est. additions | Est. reductions | Est. net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $14,603,341 | $0 | $0 | $0 | TIL | 13F-HR | 31 Jul 2026, 11:35 |
| Q1 2026 | 1 | $15,647,793 | $0 | $0 | $0 | TIL | 13F-HR | 29 Apr 2026, 13:21 |
| Q4 2025 | 1 | $20,889,044 | $0 | $0 | $0 | TIL | 13F-HR | 03 Feb 2026, 12:51 |
| Q3 2025 | 1 | $33,916,211 | $0 | $0 | $0 | TIL | 13F-HR | 03 Nov 2025, 13:18 |
| Q2 2025 | 1 | $39,556,253 | $0 | $0 | $0 | Instil Bio, Inc. | 13F-HR | 29 Jul 2025, 13:14 |
| Q1 2025 | 1 | $32,966,709 | $0 | $0 | $0 | Instil Bio, Inc. | 13F-HR | 30 Apr 2025, 10:29 |
| Q4 2024 | 1 | $36,251,986 | $0 | $0 | $0 | TIL | 13F-HR | 29 Jan 2025, 15:41 |
| Q3 2024 | 1 | $127,840,949 | $0 | $0 | $0 | TIL | 13F-HR | 31 Oct 2024, 13:24 |
| Q2 2024 | 1 | $19,540,751 | $0 | $0 | $0 | TIL | 13F-HR | 16 Jul 2024, 18:55 |
| Q1 2024 | 1 | $20,509,243 | $0 | $0 | $0 | TIL | 13F-HR | 08 May 2024, 14:09 |
| Q4 2023 | 1 | $14,470,411 | $0 | -$274,937,756 | -$274,937,756 | TIL | 13F-HR | 12 Feb 2024, 06:16 |
| Q3 2023 | 1 | $16,255,471 | $0 | $0 | $0 | TIL | 13F-HR | 13 Nov 2023, 10:31 |
| Q2 2023 | 1 | $20,927,020 | $0 | $0 | $0 | TIL | 13F-HR | 02 Aug 2023, 15:06 |
| Q1 2023 | 1 | $25,104,828 | $0 | $0 | $0 | TIL | 13F-HR | 08 May 2023, 16:56 |
| Q4 2022 | 1 | $23,927,446 | $0 | $0 | $0 | TIL | 13F-HR | 30 Jan 2023, 15:41 |
| Q3 2022 | 1 | $183,824,000 | $0 | $0 | $0 | TIL | 13F-HR | 10 Nov 2022, 11:55 |
| Q2 2022 | 1 | $175,468,000 | $0 | $0 | $0 | TIL | 13F-HR | 04 Aug 2022, 15:06 |
| Q1 2022 | 1 | $0 | $0 | $0 | $0 | 13F-HR | 13 May 2022, 11:30 | |
| Q4 2021 | 1 | $0 | $0 | $0 | $0 | 13F-HR | 14 Feb 2022, 10:29 |
Showing 1-19 of 19 filings.
Manager details and filing context
- Latest 13F filing
- Q2 2026 - 31 Jul 2026
- Latest reported 13F value
- $14,603,341
- Largest 13F holdings
-
TIL
- Form 13F summary
-
- Curative Ventures V LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Curative Ventures V LLC reported 1 equity holding with a total reported market value of $14,603,341 for Q2 2026.
- Manager signature
- Bronson Crouch - Manager of CV-Immetacyte Manager LP
- Manager location
- Dallas, TX
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Holdings Value